I have sent a message to investor relations to help me understand exactly how many outstanding shares there will be if the iAnthus/MPX Bioceuticals combination is approved (the board was unanimous when first announced).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.